One-tube real-time isothermal amplification assay to identify and distinguish human immunodeficiency virus type I subtypes A, B, and C and circulating recombinant forms AE and ag

Journal of Clinical Microbiology

Volumn 39, Issue 5, 2001, Pages 1895-1902

  De Baar, M P ^a   Timmermans, E C ^a   Bakker, M ^a   De Rooij, E ^a   Van Gemen, B ^a   Goudsmit, J ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORINE DERIVATIVE; GAG PROTEIN; VIRUS RNA;

ARTICLE; CLINICAL ARTICLE; GENE AMPLIFICATION; GENE SEQUENCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS; VIRUS CHARACTERIZATION; VIRUS GENE; VIRUS RECOMBINANT; VIRUS TYPING;

BASE SEQUENCE; DNA PRIMERS; HIV INFECTIONS; HIV-1; HUMANS; MOLECULAR SEQUENCE DATA; RECOMBINATION, GENETIC; RNA, VIRAL; SELF-SUSTAINED SEQUENCE REPLICATION; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS, DNA;

EID: 0035009916     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.39.5.1895-1902.2001     Document Type: Article

References (41)

1. Subtype-specific problems with quantification of plasma HIV-1 RNA
2. Diversity of antibody binding to V3 peptides representing consensus sequences of HIV type 1 genotypes A to E: An approach for HIV type 1 serological subtyping
3. Rapid and simple method for purification of nucleic acids
4. Serotyping of HIV type 1 infections: Definition, relationship to viral genetic subtypes, and assay evaluation. UNAIDS Network for HIV-1 Isolation and Characterization
5. A branched DNA signal amplification assay for quantification of nucleic acid targets below 100 molecules/ml
6. Human immunodeficiency virus type 1 subtypes defined by env show high frequency of recombinant gag genes
7. Design and evaluation of a human immunodeficiency virus type 1 RNA assay using nucleic acid sequence-based amplification technology able to quantify both group M and O viruses by using the long terminal repeat as target
8. Single rapid real-time monitored isothermal RNA amplification assay for quantification of human immunodeficiency virus type 1 isolates from groups M, N, and O
9. Failure to quantify viral load with two of the three commercial methods in a pregnant woman harboring an HIV type 1 subtype G strain
10. Isolation and partial characterization of an unusual human immunodeficiency retrovirus from two persons of west-central African origin
11. Genetic relationships determined by a DNA heteroduplex mobility assay: Analysis of HIV-1 env genes
12. AIDS prognosis based on HIV-1 RNA, CD4+ T-cell count and function: Markers with reciprocal predictive value over time after seroconversion
13. Evaluation of the ultrasensitive Roche Amplicor HIV-1 monitor assay for quantitation of human immunodeficiency virus type 1 RNA
14. Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission
15. Reactivity and amplification efficiency of the NASBA HIV-1 RNA amplification system with regard to different HIV-1 subtypes
16. Isothermal, in vitro amplification of nucleic acids by a multienzyme reaction modeled after retroviral replication
17. Simplified strategy for detection of recombinant human immunodeficiency virus type 1 group M isolates by gag/env heteroduplex mobility assay
18. The natural history of HIV-1 infection: Virus load and virus phenotype independent determinants of clinical course?
19. NASBA isothermal enzymatic in vitro nucleic acid amplification optimized for the diagnosis of HIV-1 infection
20. A simple method for estimating evolutionary rates of base substitution through comparative studies of nucleotide sequences
21. Multiplex detection of single-nucleotide variations using molecular beacons
22. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion
23. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma
24. Development of calibrated viral load standards for group M subtypes of human immunodeficiency virus type 1 and performance of an improved AMPLICOR HIV-1 MONITOR test with isolates of diverse subtypes
25. Lack of correlation between V3-loop peptide enzyme immunoassay serologic subtyping and genetic sequencing
26. Clinical comparison of an enhanced-sensitivity branched-DNA assay and reverse transcription-PCR for quantitation of human immunodeficiency virus type 1 RNA in plasma
27. Evaluation of a second-generation nucleic acid sequence-based amplification assay for quantification of HIV type 1 RNA and the use of ultrasensitive protocol adaptations
28. Evaluation of different V3 peptides in an enzyme immunoassay for specific HIV type 1 group O antibody detection
29. V3 serotyping of HIV-1 infection: Correlation with genotyping and limitations
30. Viral load and heterosexual transmission of human immunodeficiency virus type 1
31. HIV-1 nomenclature proposal
32. HIV viral load markers in clinical practice
33. Identification of a new human immunodeficiency virus type 1 distinct from group M and group O
34. Multicolor molecular beacons for allele discrimination
35. Molecular beacons: Probes that fluoresce upon hybridization
36. TREECON for Windows: A software package for the construction and drawing of evolutionary trees for the Microsoft Windows environment
37. Qualitative and quantitative detection of HIV-1 RNA by nucleic acid sequence-based amplification
38. Quantification of HIV-1 RNA in plasma using NASBA during HIV-1 primary infection
39. A one-tube quantitative HIV-1 RNA NASBA nucleic acid amplification assay using electrochemiluminescent (ECL) labelled probes
40. Multiplex detection of four pathogenic retroviruses using molecular beacons
41. HIV-1 subtypes: Implications for epidemiology, pathogenicity, vaccines and diagnostics